Brainsway Ltd.
Brainsway Ltd is a Healthcare company operating in Medical Devices with a $675.8M market cap.
Most recent earnings call: Q1 FY26 on May 13, 2026.
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks BRSYF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BRSYF.
$ curl https://api.spokenalpha.com/v1/companies/BRSYFFAQ
Spoken Alpha indexes BRSYF's earnings call transcripts at https://spokenalpha.com/companies/BRSYF. Each call links to attributed speakers and parsed analyst Q&A. Brainsway Ltd.'s own investor relations page is at https://investors.brainsway.com/.
Brainsway Ltd. (BRSYF) held its most recent earnings call on 2026-05-13, covering fiscal Q1 2026.
Brainsway Ltd. (BRSYF) operates in the Healthcare sector (Medical Devices industry).
Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.05 | $2.54 | +20.0% | +2.9% | +1.7% |
| Q4 FY2026 | $3.14 | $2.57 | +22.0% | +4.0% | +4.1% |
| Q3 FY2026 | $3.47 | $2.65 | +30.8% | -2.5% | -4.6% |
| Q2 FY2026 | $3.23 | $2.64 | +22.4% | +0.5% | -0.7% |
| Q1 FY2025 | $3.28 | $2.61 | +25.6% | +0.3% | +3.2% |
| Q4 FY2025 |
| $3.39 |
| $2.62 |
| +29.4% |
| +5.3% |
| +3.1% |
| Q3 FY2025 | $3.04 | $2.62 | +15.9% | +4.6% | +1.8% |
| Q2 FY2025 | $3.67 | $2.79 | +31.4% | -3.7% | -6.6% |
| Q1 FY2024 | $3.57 | $2.83 | +26.2% | -0.4% | -0.2% |
| Q4 FY2024 | $3.18 | $2.59 | +22.7% | +3.2% | +5.5% |